EichorEICHOR
Location: Decatur Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Decatur

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Cancer Care Specialists of Illinois · Pfizer · NCT07028853MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Cancer Care Specialists of Illinois - Decatur · National Cancer Institute (NCI) · NCT05564390A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Metro Infectious Diseases Consultants L.L.C. ( Site 1509) · Merck Sharp & Dohme LLC · NCT07266831A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · CenExel iResearch, LLC · Bristol-Myers Squibb · NCT06929273Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Cancer Care Specialists of Illinois - Decatur · NRG Oncology · NCT05624996Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Cancer Care Specialists of Illinois - Decatur · Alliance for Clinical Trials in Oncology · NCT07321652Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Phase 2 · CenExel iResearch · Novartis Pharmaceuticals · NCT07467993A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · Hope Clinic of the Emory Vaccine Center ( Site 0009) · Merck Sharp & Dohme LLC · NCT07044297Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Cancer Care Specialists of Illinois - Decatur · Alliance for Clinical Trials in Oncology · NCT07091617A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Accel Research - NeuroStudies, Merz Investigational Site #00 · Merz Therapeutics GmbH · NCT07018700A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · Metro Infectious Disease Consultants, P.L.L.C. · Gilead Sciences · NCT07645287A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · DeKalb Medical Center · Agendia · NCT03053193Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Phase 1 · Bioxcel Clinical Research Site · BioXcel Therapeutics Inc · NCT05025605Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Emory Decatur Hospital · NRG Oncology · NCT05946213A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalati
Phase 1 · The Hope Clinic of Emory University · National Institute of Allergy and Infectious Diseases (NIAID · NCT07536308Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Phase 4 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT05648591EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Joseph Maxwell Cleland Atlanta VA Medical Center · Boehringer Ingelheim · NCT06531824A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Cancer Care Specialists of Illinois · Amgen · NCT07005128CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
NA · Atlanta VA Medical and Rehab Center, Decatur, GA · VA Office of Research and Development · NCT05996328A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mou
Phase 1/Phase 2 · Hope Clinic of the Emory Vaccine Center · Cocrystal Pharma, Inc. · NCT07198139Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)
Phase 2 · Emory Long Term Acute Care (LTAC) · Emory University · NCT06321536Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Cancer Care Specialists of Illinois - Decatur · NRG Oncology · NCT05174169Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Orita Clinical Research · Eli Lilly and Company · NCT07353931Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Cancer Care Specialists of Illinois - Decatur · Alliance for Clinical Trials in Oncology · NCT06632327Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Cancer Care Specialists of Illinois - Decatur · Alliance for Clinical Trials in Oncology · NCT06931340Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I
Phase 3 · Alkermes Investigator Site · Alkermes, Inc. · NCT05303064Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06480383A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Out
Phase N/A · Cancer Care Specialists of Central Illinois · Novartis Pharmaceuticals · NCT07091019Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or
Phase 2 · Emory University · NCT07140679
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.